Appeal No. 2001-0992 Page 5 Application No. 08/527,880 associated non-Hodgkin’s lymphoma (see e.g., Answer, page 8, “[t]he prior art use of gallium nitrate to treat NHL generally would have motivated the skilled artisan to employ these compounds to treat non-Hodgkin’s lymphoma in any patient population….”), obvious-to-try, however, is not the standard of obviousness under 35 U.S.C. § 103. See In re O’Farrell, 858 F.2d 894, 903, 7 USPQ2d 1673, 1680 (Fed. Cir. 1988). Accordingly, we reverse the rejection of claims 1-5 under 35 U.S.C. § 103 as being unpatentable over Hart in view of Warrell I, Warrell II, and Warrell III. REVERSED Sherman D. Winters ) Administrative Patent Judge ) ) ) ) BOARD OF PATENT William F. Smith ) Administrative Patent Judge ) APPEALS AND ) ) INTERFERENCES ) Donald E. Adams ) Administrative Patent Judge )Page: Previous 1 2 3 4 5 6 NextLast modified: November 3, 2007